Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01034852 · ClinicalTrials.gov registry record

Efficacy Study for Surgery After Previous Failed Catheter Ablation

A clinical trial of Atrial Fibrillation Ablation, sponsored by Cardiopulmonary Research Science and Technology Institute.

Completed
Registry status
45
Enrollment target
2
Study locations

NCT01034852 is a study of Atrial Fibrillation Ablation that has completed, run by Cardiopulmonary Research Science and Technology Institute. The registered enrollment target is 45 participants. The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01034852, a study of Atrial Fibrillation Ablation, has completed, sponsored by Cardiopulmonary Research Science and Technology Institute.

COMPLETED
Registry status
45 participants
Enrollment target
2
Study locations

Study Summary

Specific Aims: The primary objective of this registry is to determine the percentage of patients who are free from atrial fibrillation (AF) at 6 and 12 months following a surgical ablation procedure when the patient has a history of failing one or more previous catheter based ablations for AF. The first 3 months following surgical ablation will be a blanking period; any arrhythmia occurring during this time will not be used to determine success. Primary Objectives: 1. Determine the percent success of surgical ablation for AF at 6, and 12 months both on and off of antiarrhythmic drugs (AAD) following a failed catheter based ablation for AF 2. Record and evaluate all complications associated with the surgical procedure. Secondary Objectives: 1. Evaluate usage of anticoagulants at 6, and 12 months. 2. Determine the percentage of Pulmonary Veins (PV) that were electrically isolated by intra-operative, pre-surgical mapping

Interventions

  • PROCEDURE Totally Thoracoscopic Maze

Study Locations (2)

Oregon

  • Endovascular Research - Springfield

Texas

  • Cardiopulmonary Research Science and Technology Institute - Dallas

Trial Details

FieldValue
Enrollment Target 45 participants
Start Date 2009-05
Est. Completion 2011-01

What the Registry Record Tells You About NCT01034852

The ClinicalTrials.gov registry entry for NCT01034852 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cardiopulmonary Research Science and Technology Institute, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Atrial Fibrillation Ablation appearing as the primary indexed condition, and to 1 intervention - of which Totally Thoracoscopic Maze is the first listed.

NCT01034852 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Oregon, Texas.

Frequently Asked Questions

What is clinical trial NCT01034852 about?

NCT01034852 is a clinical study titled "Efficacy Study for Surgery After Previous Failed Catheter Ablation". Specific Aims: The primary objective of this registry is to determine the percentage of patients who are free from atrial fibrillation (AF) at 6 and 12 months following a surgical ablation procedure when the patient has a history of failing one or more previous catheter based ablations for AF. The f...

What is the current status of trial NCT01034852?

This trial is currently completed. The enrollment target is 45 participants. The study started on 2009-05. Estimated completion is 2011-01.

What conditions does trial NCT01034852 study?

This clinical trial studies the following conditions: Atrial Fibrillation Ablation.

What interventions are being tested in trial NCT01034852?

The interventions under investigation include: Totally Thoracoscopic Maze (PROCEDURE).

Who is sponsoring clinical trial NCT01034852?

This trial is sponsored by Cardiopulmonary Research Science and Technology Institute, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01034852 being conducted?

This trial has 2 study locations across Oregon, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.